Back to AG Adage Capital Partners GP, L.L.C.

XENEXENE

Showing 8 of 31 quarters

Position history for AGAdage Capital Partners GP, L.L.C.'s holdings in Xenon Pharmaceuticals Inc.

Yes. Adage Capital Partners GP holds 300,000 shares of XENE (Xenon Pharmaceuticals), worth $18.1M, as of its Q2 2026 13F filing. It reduced the position by 170,000 shares (-36.2%) from Q1 2026. Adage Capital Partners GP has held XENE in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$18.1M

Current Shares

300,000

Total Value Change

-$63.9M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
300,000
-36.2%
$18.1M0.0%$60.36
0
2026-Q1
Decreased
470,000
-31.4%
$27.3M0.0%—
0
2025-Q4
Decreased
685,100
-18.0%
$30.7M0.0%—
0
2025-Q3
Decreased
835,100
-35.3%
$33.5M0.1%—
0
2025-Q2
Decreased
1.3M
-32.6%
$40.4M0.1%—
0
2025-Q1
Increased
1.9M
+2.8%
$64.2M0.1%—
36
2024-Q4
Decreased
1.9M
-10.6%
$73M0.1%—
0
2024-Q3
Increased
2.1M
+13.3%
$82M0.1%$38.65
40

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used